{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:31:22Z","timestamp":1792643482182,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.resmer.2025.101191","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T16:59:28Z","timestamp":1752857968000},"page":"101191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting \u03b22 adrenergic agonist: a randomized phase 2 screening trial"],"prefix":"10.1016","volume":"88","author":[{"given":"Fumiya","family":"Nihashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4079-5509","authenticated-orcid":false,"given":"Kazuki","family":"Furuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Niwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotsugu","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kaida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Toyoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Koshimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Yasui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironao","family":"Hozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Karayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2025.101191_bib0002","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.alit.2023.02.006","article-title":"Executive summary: Japanese guidelines for adult asthma (JGL) 2021","volume":"72","author":"Niimi","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.resmer.2025.101191_bib0003","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0004","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-2600(15)00031-4","article-title":"Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials","volume":"3","author":"Kerstjens","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jaci.2011.04.039","article-title":"Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial","volume":"128","author":"Kerstjens","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resmer.2025.101191_bib0006","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0007","article-title":"Addition to inhaled corticosteroids of long-acting \u03b22 -agonists versus anti-leukotrienes for chronic asthma","volume":"24","author":"Chauhan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resmer.2025.101191_bib0008","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1164\/ajrccm.155.4.9105060","article-title":"Leukotriene antagonist prevents exacerbation of asthma during reduction of high-dose inhaled corticosteroid. The Tokyo Joshi Idai Asthma Research Group","volume":"155","author":"Tamaoki","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0009","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1046\/j.1365-2745.2002.01440.x","article-title":"Leukotriene receptor antagonist, montelukast, can reduce the need for inhaled steroid while maintaining the clinical stability of asthmatic patients","volume":"32","author":"Tohda","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.resmer.2025.101191_bib0010","doi-asserted-by":"crossref","unstructured":"Hoshino M., Akitsu K., Ohtawa J. Comparison between montelukast and tiotropium as add-on therapy to inhaled corticosteroids plus a long-acting \u03b22-agonist in for patients with asthma J Asthma. 56 (2019) 995\u20131003.","DOI":"10.1080\/02770903.2018.1514047"},{"key":"10.1016\/j.resmer.2025.101191_bib0011","first-page":"19476","article-title":"Assessment of second-line treatments for patients with uncontrolled moderate asthma","volume":"8","author":"Wang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0012","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1200\/JCO.2005.01.149","article-title":"Design issues of randomized phase II trials and a proposal for phase II screening trials","volume":"23","author":"Rubinstein","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.resmer.2025.101191_bib0013","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1164\/ajrccm.152.3.7663792","article-title":"Standardization of spirometry, 1994 update","volume":"152","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0014","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rmed.2004.10.008","article-title":"Measurement properties and interpretation of three shortened versions of the asthma control questionnaire","volume":"99","author":"Juniper","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0015","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.rmed.2005.08.012","article-title":"GOAL committee, identifying \u2018well-controlled\u2019 and \u2018not well-controlled\u2019 asthma using the asthma control questionnaire","volume":"100","author":"Juniper","year":"2006","journal-title":"Respir Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0016","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1081-1206(10)60223-2","article-title":"Relationship of the asthma control test with pulmonary function and exhaled nitric oxide","volume":"101","author":"Shirai","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.resmer.2025.101191_bib0017","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaci.2006.01.011","article-title":"Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists","volume":"117","author":"Schatz","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resmer.2025.101191_bib0018","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0019","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transpl"},{"key":"10.1016\/j.resmer.2025.101191_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(20)30389-1","article-title":"Efficacy and safety of once-daily single-inhaler triple therapy (FF\/UMEC\/VI) versus FF\/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial","volume":"9","author":"Lee","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0021","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2021.7872","article-title":"Triple vs dual inhaler therapy and asthma outcomes in moderate to severe asthma: a systematic review and meta-analysis","volume":"325","author":"Kim","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.resmer.2025.101191_bib0022","article-title":"Addition of anti-leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma","volume":"3","author":"Chauhan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resmer.2025.101191_bib0023","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1398-9995.2006.01007.x","article-title":"Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial","volume":"61","author":"Price","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.resmer.2025.101191_bib0024","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01208-2019","article-title":"ERS\/TSANZ task force statement on the management of reproduction and pregnancy in women with airways diseases","volume":"55","author":"Middleton","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resmer.2025.101191_bib0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1513\/AnnalsATS.201410-459OC","article-title":"Primary adherence to controller medications for asthma is poor","volume":"12","author":"Wu","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resmer.2025.101191_bib0026","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1398-9995.2011.02676.x","article-title":"Prevalence and impact of rhinitis in asthma. SACRA, a cross-sectional nation-wide study in Japan","volume":"66","author":"Ohta","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.resmer.2025.101191_bib0027","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1010846","article-title":"Leukotriene antagonists as first-line or add-on asthma-controller therapy","volume":"364","author":"Price","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resmer.2025.101191_bib0028","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12931-022-02114-6","article-title":"Effects of treatment with montelukast alone, budesonide\/formoterol alone and a combination of both in cough variant asthma","volume":"23","author":"Yi","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.resmer.2025.101191_bib0029","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13223-021-00564-z","article-title":"Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: a meta-analysis of current evidence","volume":"17","author":"Feng","year":"2021","journal-title":"Allergy Asthma Clin Immunol"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041225000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:39:18Z","timestamp":1763829558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041225000388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":28,"alternative-id":["S2590041225000388"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101191","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-acting muscarinic antagonist versus leukotriene receptor antagonist as additional treatment in uncontrolled asthma patients used inhaled corticosteroids and long-acting \u03b22 adrenergic agonist: a randomized phase 2 screening trial","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2025.101191","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 SPLF and Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101191"}}